Evidence-Based Guidelines for SARS-COV-2 Vaccination of Patients of Skin Allergic Diseases and Patients on Immuno-Therapeutics

There is a dearth of data regarding the safety and timing of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) vaccination of patients on immunosuppressive or immunomodulatory therapies. However, data from other vaccine trials may be extrapolated to get an idea regarding the recommend...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Anupam, De, Abhishek, Godse, Kiran, Sangolli, Prabhakar, Zawar, Vijay, Sharma, Nidhi, Girdhar, Mukesh, Podder, Indrashis, Shah, Bela, Dhar, Sandipan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644747/
https://www.ncbi.nlm.nih.gov/pubmed/36386095
http://dx.doi.org/10.4103/ijd.ijd_440_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644747/
https://www.ncbi.nlm.nih.gov/pubmed/36386095
http://dx.doi.org/10.4103/ijd.ijd_440_21

Ejemplares similares